12-time Major League Baseball All-Star and Hall-of-Famer Dave Winfield knows the impact multiple myeloma can have on a patient all too well. In 2017, his close friend and former teammate Don Baylor passed away following a 14-year battle with the disease. Together with Don’s son, Dave is committed to helping raise awareness of this incurable blood cancer.
Steve Garvey is a 10-time MLB All-Star and former World Series champion. He saw firsthand the impact of multiple myeloma, when his father-in-law was diagnosed and later passed away from the disease. Steve is urging patients to play an active role in their treatment by creating a plan for managing multiple myeloma.
Son of Don Baylor, a former Major League Baseball player and coach who passed away following a 14-year battle with multiple myeloma. Following his diagnosis, Don Sr. worked hard to raise awareness and funds to help fight this incurable disease. Don Jr. has partnered with Amgen to build on his father’s work.
The multiple myeloma treatment landscape has evolved significantly over the past decade. With so many options available, treatment can be individualized to your situation. However, your doctor needs to be aware of your lifestyle preferences and priorities to provide the right treatment options for you. The following steps will help you think through your priorities, so you can better communicate with your doctor and work together to make effective treatment decisions.
“If you or someone you love is up against multiple myeloma, you’re not alone. The right strategy can help you manage this complex disease.”Steve Garvey10-time MLB All-Star
As the playoff race heats up, Myeloma MVP will be in attendance at the following games this summer to recognize local patients and raise awareness:August 26: Tampa Bay RaysSeptember 16: Houston AstrosSpecial thanks to the Astros and Rays for participating in this campaign to spread the word about multiple myeloma. For more information about these and other upcoming events, sign up for email updates from Myeloma Explained.
We look forward to sharing updates in the futureClose window
Would you like to proceed?
The sponsors of this site are not responsible for content on the site you are about to enter. Would you like to proceed?